Medable was founded with the mission to accelerate the development of effective therapies by streamlining clinical research processes. The company offers a comprehensive, global cloud platform designed to facilitate collaboration among sponsors, patients, providers, and Contract Research Organizations (CROs). Medable's suite of tools aims to simplify and speed up clinical trials, ensuring high-quality data collection and management. Their market focus is on enhancing the efficiency and scalability of clinical research to bring therapies to patients faster.
Notable figures associated with Medable include its founders and key investors who have significantly contributed to its growth. The company has achieved recognition for its innovative approach to clinical trials, partnering with organizations like Pluto Health to improve patient experiences and access to clinical trials. Medable's impact is evident in its ability to streamline complex research processes, thereby accelerating the delivery of new therapies to the market.
